Magle Chemoswed Holding AB (publ) MAGLE.ST
MAGLE.ST
Magle Chemoswed Holding AB (publ) GUARD.ST
Guard Therapeutics International AB (publ) XBRANE.ST
Xbrane Biopharma AB (publ) CLBIO.ST
Corline Biomedical AB IVACC.ST
Intervacc AB (publ) ELIC.ST
Elicera Therapeutics AB (publ) ACE.ST
Ascelia Pharma AB (publ) XINT.ST
Xintela AB (publ) IMMU.ST
Mendus AB (publ) MOB.ST
Moberg Pharma AB (publ)
Magle Chemoswed Holding AB (publ) GUARD.ST
Guard Therapeutics International AB (publ) XBRANE.ST
Xbrane Biopharma AB (publ) CLBIO.ST
Corline Biomedical AB IVACC.ST
Intervacc AB (publ) ELIC.ST
Elicera Therapeutics AB (publ) ACE.ST
Ascelia Pharma AB (publ) XINT.ST
Xintela AB (publ) IMMU.ST
Mendus AB (publ) MOB.ST
Moberg Pharma AB (publ)
Performance
| Periode | MAGLE.ST | GUARD.ST | XBRANE.ST | CLBIO.ST | IVACC.ST | ELIC.ST | ACE.ST | XINT.ST | IMMU.ST | MOB.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -32.39 % | 72.28 % | -53.74 % | 124.73 % | 6.57 % | 44.14 % | 0.00 % | 0.48 % | 20.52 % | 0.86 % |
| YTD | -49.47 % | 18.74 % | -49.39 % | 118.62 % | 20.94 % | 260.34 % | 3.26 % | 21.26 % | -28.69 % | -19.57 % |
| 1Y | -48.73 % | -0.90 % | -61.71 % | 160.60 % | -57.77 % | 210.40 % | 46.76 % | -8.26 % | -40.69 % | -31.89 % |
| 3Y | -28.09 % | -32.91 % | -99.87 % | 145.31 % | -95.66 % | 57.34 % | -82.85 % | -0.59 % | -84.86 % | -43.97 % |
| 5Y | -41.50 % | -64.99 % | -99.88 % | 23.88 % | -97.11 % | 1.13 % | -92.03 % | -87.13 % | -96.65 % | -87.28 % |
| 10Y | -4.43 % | -99.17 % | -99.73 % | 85.27 % | -81.52 % | 1.13 % | -87.26 % | -89.88 % | -98.97 % | -97.39 % |
| From the beginning | -4.43 % | -99.37 % | -99.73 % | 106.06 % | -81.52 % | 1.13 % | -87.26 % | -89.88 % | -16.57 % | -94.99 % |